false 0001786352 0001786352 2026-11-19 2026-11-19
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2026

 

 

BILL Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39149   83-2661725

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

6220 America Center Drive, Suite 100

San Jose, California

  95002
(Address of principal executive offices)   (Zip Code)

(650) 621-7700

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☒

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.00001 par value per share   BILL   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01 Entry into a Material Definitive Agreement.

Agreement and Plan of Merger

On November 19, 2026, BILL Holdings, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Blizzard Borrower 2026, Inc., a Delaware corporation (“Parent”), and Blizzard Merger Sub 2026, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Parent and Merger Sub are entities affiliated with funds managed by affiliates of TPG, the global alternative asset management firm (such investment funds, the “Sponsor Guarantors”). Corpay, Inc. (“Corpay”) will also be a direct or indirect investor in Parent.

Pursuant to the terms, and subject to the conditions, of the Merger Agreement, at the effective time of the Merger (the “Effective Time”), and by virtue of the Merger, and without any action on the part of Parent, Merger Sub, the Company or the holders of any securities of the Company, each share of common stock, $0.00001 par value per share, of the Company (“Company Common Stock”) that is issued and outstanding immediately prior to the Effective Time (other than (i) shares of Company Common Stock owned or held in treasury by the Company, Parent or any of their respective subsidiaries immediately prior to the Effective Time (which will be automatically canceled at the Effective Time for no consideration) and (ii) shares of Company Common Stock held by holders who have not voted in favor of the adoption of the Merger Agreement or consented thereto in writing, who are entitled to and have properly exercised appraisal rights under Section 262 of the Delaware General Corporation Law and who have not effectively withdrawn or lost such holders’ rights to appraisal for such shares) will be automatically canceled and cease to exist, and will thereafter represent only the right to receive cash in an amount equal to $63.25 per share (as may be adjusted pursuant to the Merger Agreement, the “Merger Consideration”), payable to the holder thereof, without interest, subject to any required withholding of taxes.

If the Company Warrants (as defined in the Merger Agreement) remain outstanding immediately prior to the Effective Time, they will be automatically net exercised immediately prior to the Effective Time in accordance with their terms, and the shares of Company Common Stock issuable upon such net exercise will be converted into the right to receive the Merger Consideration.

The board of directors of the Company (the “Board”), by a unanimous vote of the directors present and voting, determined that the terms of the Merger Agreement and the transactions contemplated thereby, including the Merger, are fair to, and in the best interests of, the Company and its stockholders, approved and declared advisable the Merger Agreement and the transactions contemplated thereby, including the Merger, authorized and approved the execution, delivery and performance by the Company of the Merger Agreement and the consummation of the transactions contemplated thereby upon the terms and subject to the conditions set forth therein, and resolved to recommend that the stockholders of the Company adopt the Merger Agreement and directed that the Merger Agreement be submitted to the stockholders of the Company for adoption.

The stockholders of the Company will be asked to vote on the adoption of the Merger Agreement at a special stockholder meeting (the “Company Stockholder Meeting”) that will be held on a date to be announced as soon as reasonably practicable following the customary review process of the Securities and Exchange Commission (the “SEC”) of the Company’s proxy statement.

If the Merger is consummated, the Company Common Stock will be delisted from the New York Stock Exchange and deregistered under the Securities Exchange Act of 1934, as amended, and the Company will become a privately held company.

Treatment of Company Equity Awards

The Merger Agreement provides that, at the Effective Time, (i) each outstanding option to purchase Company Common Stock will be canceled and converted into the right to receive an amount in cash equal to the excess, if any, of the Merger Consideration over the exercise price per share of such option, multiplied by the number of shares subject to such option (with any option having an exercise price per share equal to or greater than the Merger Consideration canceled for no consideration), (ii) each vested restricted stock unit award and each vested performance-based restricted stock unit award (including any restricted stock units held by non-employee members of the Board, whether or not vested) will be canceled and converted into the right to receive an amount in cash equal to the Merger


Consideration multiplied by the number of shares subject to such award, (iii) each unvested restricted stock unit award will be canceled and converted into the right to receive an amount in cash equal to the Merger Consideration multiplied by the number of shares subject to such award, which amount will vest and become payable in accordance with the vesting schedule and other terms and conditions (including any accelerated vesting terms) applicable to such award immediately prior to the Effective Time and (iv) each unvested performance-based restricted stock unit award will be treated as follows: (A) with respect to any such award for which the applicable performance period has not been completed, achievement of the applicable performance metrics will be reasonably determined in good faith prior to the Effective Time by the Board or a committee thereof, following consultation with Parent, in accordance with the terms of the applicable award agreement, with any portion not determined to be achieved canceled for no consideration and the achieved portion canceled and converted into the right to receive an amount in cash equal to the Merger Consideration multiplied by the number of shares subject to such achieved portion, which amount will vest and become payable solely in accordance with the time-based vesting schedule (and will not be subject to any performance-based vesting conditions) and other terms and conditions (including any accelerated vesting terms) applicable to such award immediately prior to the Effective Time and (B) any such award for which the applicable performance period has been completed and performance has been measured prior to the Effective Time, and that remains subject to time-based vesting, will be treated in the same manner as an unvested restricted stock unit award as described above in clause (iii), with the number of shares subject thereto determined based on such measured performance. All such payments will be made without interest and less applicable taxes and authorized deductions.

Conditions to Closing

The Closing (as defined in the Merger Agreement) is subject to the satisfaction or waiver of certain customary closing conditions, including:

 

  •  

the adoption of the Merger Agreement by the holders of a majority of the outstanding shares of Company Common Stock entitled to vote thereon at the Company Stockholder Meeting (the “Company Stockholder Approval”);

 

  •  

the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of the approvals and clearances under the foreign antitrust laws of the jurisdictions specified in the Merger Agreement, with such approvals and clearances remaining in full force and effect and all statutory waiting periods relating thereto having expired or been terminated;

 

  •  

the receipt of specified consents of U.S. state regulatory authorities in connection with the change of control of the Company’s subsidiary that holds money transmitter licenses and lending and other financial services licenses, and the expiration or termination of applicable statutory waiting periods, provided that, on or after the date that is 180 days after the date of the Merger Agreement, any such consents with respect to certain lending and other financial services licenses that have not then been obtained will not be required if alternative arrangements are implemented in the applicable jurisdictions, subject to certain conditions;

 

  •  

the absence of any binding law or order enacted, issued, enforced or entered by a governmental authority of competent jurisdiction that remains in effect and restrains, enjoins, makes illegal or otherwise prohibits consummation of the Merger;

 

  •  

the accuracy of the representations and warranties contained in the Merger Agreement and compliance with the covenants contained in the Merger Agreement, in each case, subject to customary qualifications;

 

  •  

no Material Adverse Effect (as defined in the Merger Agreement) having occurred since the date of the Merger Agreement that is continuing; and

 

  •  

the receipt of closing certificates certifying that the applicable closing conditions have been satisfied.

The availability of Parent’s financing is not a condition to the consummation of the Merger.

No-Shop

The Company is subject to customary “no-shop” restrictions on its ability to, among other things, solicit Alternative Proposals (as defined in the Merger Agreement) or furnish non-public information to, or engage in discussions or negotiations with, third parties regarding Alternative Proposals. These restrictions are subject to exceptions that permit the Company, before obtaining the Company Stockholder Approval and in specified circumstances, to furnish non-public information pursuant to an Acceptable Confidentiality Agreement and engage in discussions or negotiations regarding a bona fide written Alternative Proposal that constitutes, or would reasonably be expected to lead to or result in, a Superior Proposal (each as defined in the Merger Agreement).

Before obtaining the Company Stockholder Approval, the Board may, in specified circumstances, effect an Adverse Recommendation in response to an Intervening Event (each as defined in the Merger Agreement) or a


Superior Proposal, or terminate the Merger Agreement to accept a Superior Proposal, subject to the Board’s determination that the failure to take such action would be inconsistent with its fiduciary duties, Parent’s notice and matching rights and, where applicable, payment of the termination fee described below.

Termination and Fees

The Merger Agreement provides for termination by mutual written consent and certain termination rights for the Company and Parent, including if the Merger is not completed by November 19, 2027, if a final, nonappealable order or law is enacted, issued or promulgated that permanently restrains, enjoins, prohibits or otherwise makes illegal the consummation of the Merger, if the Company Stockholder Meeting has concluded and the Company Stockholder Approval has not been obtained, or following certain uncured breaches. Subject to the Merger Agreement’s conditions, Parent may also terminate following an Adverse Recommendation, and the Company may terminate to accept a Superior Proposal before obtaining the Company Stockholder Approval or if Parent and Merger Sub fail to close when required.

The Company must pay a termination fee of $180.51 million to an affiliate of TPG Global, LLC and to Corpay, each in accordance with its Pro Rata Share (as defined in the Merger Agreement), upon termination in specified circumstances, including to accept a Superior Proposal, following an Adverse Recommendation, or in specified circumstances when the Company consummates an Acquisition Transaction (as defined in the Merger Agreement) or enters into a definitive acquisition agreement providing for an Acquisition Transaction within one year following such termination.

Parent must pay the Company a termination fee of $421.18 million if the Merger Agreement is terminated (i) by the Company due to certain uncured breaches by Parent or Merger Sub or a failure by Parent and Merger Sub to consummate the Closing when required or (ii) by Parent because the Merger has not been completed by November 19, 2027 at a time when the Company had the right to terminate the Merger Agreement for either of the reasons described in clause (i). Subject to the Company’s right to specific performance and certain other exceptions, if the Parent termination fee becomes payable, the Company’s receipt of such fee will be the sole and exclusive remedy of the Company and its related parties against Parent, Merger Sub, the Guarantors (as defined below) and their related parties, and in no event will the aggregate liability of Parent and its related parties to the Company and its related parties, or of the Company and its related parties to Parent and its related parties (taking into account any payment of the Company termination fee), in respect of the Merger Agreement and the transactions contemplated thereby exceed the amount of the Parent termination fee (plus, in the case of the liability of Parent and its related parties, certain reimbursement obligations and, in each case, any enforcement expenses described below).

Each of the Sponsor Guarantors and Corpay (each, a “Guarantor”) has guaranteed certain obligations of Parent in connection with the Merger Agreement, subject to the terms and conditions of its guarantee. The obligations of each Guarantor under its guarantee are several, and not joint or joint and several, are limited to such Guarantor’s Pro Rata Share of the guaranteed obligations and are subject to the cap set forth in its guarantee.

The Merger Agreement also provides for reimbursement of enforcement expenses and payment of interest in specified circumstances involving a failure to pay a termination fee when due, subject to an aggregate cap of $5,000,000.

Financing

Parent has secured committed equity financing on the terms and subject to the conditions set forth in equity commitment letters with each of the Sponsor Guarantors and Corpay, and committed debt financing from certain lenders on the terms and subject to the conditions set forth in a debt commitment letter. Parent has represented in the Merger Agreement that the aggregate proceeds of the equity and debt financing, when funded in accordance with those commitment letters, will be sufficient to pay the aggregate Merger Consideration and the amounts payable in respect of the Company’s equity awards, repay, redeem, settle or refinance certain indebtedness of the Company and its subsidiaries (including amounts due in respect of the Company’s outstanding convertible notes) and pay related fees and expenses required to be paid at the Closing. Pursuant to the Merger Agreement, the Company is required to use its reasonable best efforts to provide Parent with customary cooperation in connection with the debt financing.

 


Other Terms of the Merger Agreement

The Merger Agreement contains customary representations, warranties and covenants, including, among others, covenants by the Company to use commercially reasonable efforts to conduct its business and operations in all material respects in the ordinary course between execution of the Merger Agreement and the Closing, not to engage in certain transactions during that period (including the payment of dividends) without Parent’s prior written consent, subject to specified exceptions, to convene and hold a meeting of its stockholders to consider and vote upon the adoption of the Merger Agreement, to seek regulatory approvals, and, subject to specified exceptions, for the Board to recommend that its stockholders adopt the Merger Agreement. The Merger Agreement also contains representations, warranties and covenants of Parent and Merger Sub, including obligations to use reasonable best efforts to obtain regulatory approvals and financing.

The Merger Agreement also provides that either party may specifically enforce the other party’s obligations under the Merger Agreement; provided, that the Company may cause Parent to cause the equity financing to be fully funded and to effect the Closing only if certain conditions have been satisfied.

A copy of the Merger Agreement is attached hereto as Exhibit 2.1 and is incorporated herein by reference. The foregoing description of the Merger Agreement is only a summary, does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement.

The Merger Agreement has been attached as an exhibit to provide investors and stockholders with information regarding its terms. It is not intended to provide any other factual information about the Company, Parent or Merger Sub. The representations, warranties and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement and as of specified dates, were solely for the benefit of the parties to the Merger Agreement, and may be subject to limitations agreed upon by the contracting parties. The representations and warranties may have been made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors and stockholders accordingly should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Parent, Merger Sub or any of their respective subsidiaries or affiliates. In addition, the assertions embodied in the representations and warranties contained in the Merger Agreement are qualified by information in confidential disclosure schedules that the Company exchanged with Parent and Merger Sub in connection with the execution of the Merger Agreement. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. The Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the parties to the Merger Agreement and the Merger that will be contained in, or incorporated by reference into, the proxy statement that the Company will file in connection with the Merger, as well as in the Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other documents that the Company has filed or may file with the SEC.

Voting and Support Agreement

René Lacerte, certain of his affiliated entities and entities affiliated with Starboard Value LP (collectively, the “Supporting Stockholders”) have entered into a voting and support agreement with Parent and the Company (the “Voting and Support Agreement”) with respect to all shares of Company Common Stock beneficially owned by the Supporting Stockholders as set forth in the Voting and Support Agreement (collectively, the “Covered Shares”).

As of the date of the Voting and Support Agreement, the Supporting Stockholders hold, collectively, approximately 11.1% of the voting power of Company Common Stock. Under the Voting and Support Agreement, the Supporting Stockholders have agreed to, among other things:

 

  •  

vote the Covered Shares in favor of the approval of the Merger, the adoption of the Merger Agreement and each of the other actions contemplated by the Merger Agreement; and

 


  •  

vote against (i) any Alternative Proposal or any reorganization, dissolution, liquidation, winding up or similar extraordinary transaction involving the Company, and (ii) any action, proposal, transaction or agreement that is intended to or would result in a breach in any material respect of any covenant, representation or warranty of the Supporting Stockholders under the Voting and Support Agreement or that would impede, interfere with, delay, postpone, discourage or adversely affect the consummation of the Merger or any of the other transactions expressly contemplated by the Merger Agreement or the Voting and Support Agreement, or change in any manner the voting rights of any class of shares of the Company.

The Voting and Support Agreement will automatically terminate upon the earliest to occur of (i) the Effective Time, (ii) the valid termination of the Merger Agreement in accordance with its terms, including a termination of the Merger Agreement by the Company to accept a Superior Proposal, (iii) the entry into or effectiveness of certain amendments, modifications or waivers of the Merger Agreement, including any that reduce the amount or change the form of the Merger Consideration, (iv) written notice of termination by Parent or the mutual written agreement of the parties thereto and (v) the receipt of the Company Stockholder Approval.

The foregoing description of the Voting and Support Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the form of the Voting and Support Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

Item 8.01 Other Events.

On November 19, 2026, the Company issued a press release announcing entry into the Merger Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

***

Additional Information and Where to Find It

This communication may be deemed to be solicitation material in respect of the proposed transaction involving the Company, Parent and Merger Sub. In connection with the proposed transaction, the Company intends to file a preliminary proxy statement and a definitive proxy statement with the SEC with respect to a special meeting of stockholders to be held in connection with the proposed transaction. After filing the definitive proxy statement (the “Proxy Statement”) with the SEC, the Company will mail the Proxy Statement and a proxy card to each stockholder of the Company entitled to vote at the special meeting. This communication is not a substitute for the Proxy Statement or any other document that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction. The Proxy Statement will contain important information about the proposed transaction and related matters. INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT MATERIALS FILED OR TO BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS WHEN THEY BECOME AVAILABLE BEFORE MAKING ANY VOTING DECISION WITH RESPECT TO THE PROPOSED TRANSACTION BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE PROPOSED TRANSACTION. The Proxy Statement and other relevant materials filed or to be filed with the SEC will be made available to the Company’s investors and stockholders at no expense to them and copies may be obtained free of charge on the Company’s website at https://investor.bill.com. In addition, all of those materials will be available at no charge on the SEC’s website at www.sec.gov.

Participants in the Solicitation

The Company and its directors, executive officers, other members of its management and employees may be deemed to be participants in the solicitation of proxies of the Company’s stockholders in connection with the proposed transaction under SEC rules. Investors and stockholders may obtain more detailed information regarding the names, affiliations and interests of the Company’s executive officers and directors in the solicitation by reading the Company’s definitive proxy statement for its 2026 annual meeting of stockholders, the Annual Report on Form 10-K for the fiscal year ended June 30, 2026 and the subsequent Quarterly Reports on Form 10-Q, SEC filings on Forms 3 and 4 by such directors and executive officers and the Proxy Statement and other relevant materials that will be filed with the SEC in connection with the proposed transaction when they become available. Any changes in the holdings of the Company’s securities by its directors or executive officers from the amounts described in the Company’s definitive proxy statement for its 2026 annual meeting of stockholders have been or will be reflected in Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC subsequent to the filing date of the Company’s definitive proxy statement for its 2026 annual meeting of stockholders. Such filings are or will be available on the SEC’s website at www.sec.gov. Information concerning the interests of the Company’s participants in the solicitation, which may, in some cases, be different than those of the Company’s stockholders generally, will be set forth in the Proxy Statement relating to the proposed transaction when it becomes available. Additional information regarding the identity of potential participants, and their direct or indirect interests, by security holdings


or otherwise, will be included in the Proxy Statement when it is filed with the SEC. These documents (when available) may be obtained free of charge on the Company’s website at https://investor.bill.com or from the SEC’s website at www.sec.gov.

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are statements that could be deemed “forward-looking statements,” including all statements regarding the intent, belief or current expectation of the Company and members of its senior management team. Words such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “target,” variations of such words, the negative of such words or other comparable terminology, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words.

These forward-looking statements include, among other things, statements regarding the potential benefits of and timeline of closing the proposed transaction; the prospective performance and outlook of the Company’s business and opportunities; the ability of the parties to complete the proposed transaction and the expected timing of completion of the proposed transaction, as well as any assumptions underlying any of the foregoing. These forward-looking statements are based upon current beliefs, expectations and discussions relating to the proposed transaction and are subject to risks, uncertainties and assumptions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks include, but are not limited to, risks and uncertainties related to: (i) the ability to obtain the requisite approval from stockholders of the Company; (ii) the risk that the proposed transaction may not be completed in a timely manner or at all; (iii) the possibility that competing offers or acquisition proposals for the Company will be made; (iv) the possibility that any or all of the various conditions to the consummation of the proposed transaction may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities; (v) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, including in circumstances that would require the Company to pay a termination fee or other expenses; (vi) the effect of the announcement or pendency of the proposed transaction on the Company’s ability to retain and hire key personnel, its ability to maintain relationships with its customers, suppliers and others with whom it does business, its business generally or its stock price; (vii) risks related to diverting management’s attention from the Company’s ongoing business operations or the loss of one or more members of the management team; (viii) the risk that stockholder litigation or other legal proceedings in connection with the proposed transaction may result in significant costs of defense, indemnification and liability, or may delay or prevent the completion of the proposed transaction; (ix) the Company’s ability to achieve future growth and sustain its growth rate; (x) the Company’s ability to attract and retain talent; (xi) the Company’s ability to attract and retain customers (including government customers) and increase sales to its customers; (xii) the Company’s ability to develop and release new products and services and to scale its platform; (xiii) the Company’s ability to maintain and grow its relationships with channel and strategic partners; (xiv) the highly competitive and rapidly evolving market in which it participates; (xv) the Company’s ability to identify targets for, execute on, or realize the benefits of, potential acquisitions; (xvi) its international expansion strategies; (xvii) the risk that restrictions during the pendency of the proposed transaction may impact the Company’s ability to pursue certain business opportunities or strategic transactions; and (xviii) the impact of legislative, regulatory, economic, competitive and technological changes.

These risks, as well as other risks related to the proposed transaction, will be more fully described in the Proxy Statement. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Further information on risks that could affect the Company’s results is included in its filings with the SEC, including its most recent Quarterly Report on Form 10-Q, its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, any Current Reports on Form 8-K and other filings that it may file from time to time with the SEC. Should any of these risks or uncertainties materialize, actual results could differ materially from expectations. There may be additional risks that the Company presently does not know of, or that the Company currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation to, and does not currently intend to, update any such forward-looking statements after the date of this communication, except as required by law.

 


Item 9.01 Financial Statements and Exhibits.

 

(d)

Exhibits.

 

Exhibit
Number
  

Exhibit Description

2.1    Agreement and Plan of Merger, dated as of November 19, 2026, by and among Parent, Merger Sub and the Company*
10.1    Form of Voting and Support Agreement, dated as of November 19, 2026, by and among Parent, the Company and the stockholders party thereto*
99.1    Press Release, dated November 19, 2026
104    Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

 

*

Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules and exhibits upon request by the SEC.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    BILL HOLDINGS, INC.
Date: November 20, 2026     By:  

/s/ René Lacerte

    Name:   René Lacerte
    Title:   Chairman and Chief Executive Officer

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-2.1

EX-10.1

EX-99.1

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION LABEL LINKBASE

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: d176726d8k_htm.xml